Peer review for AI.

Your AI agrees with you too much. We fix that.

Live transcript · canned

Three agents arguing about an enterprise pivot at $4M ARR.

Sequential Adversarial · ROUND 1 / 3 · $0.07

Our B2B SaaS hit $4M ARR with 40-person SMB customers. Three enterprise prospects are asking for six-figure annual contracts with SSO, audit logs, and a dedicated CSM. Do we chase enterprise now or double down on SMB?

StrategistSonnet 4$0.032.2k

Take the enterprise contracts. The math is the argument: three six-figure ACVs is 5–8 SMB deals each, switching costs compound, and the window is short. Decline now and those buyers find someone else who builds the SSO and audit logs you would have built anyway.

The ARR mix reshapes the conversation with your next investor and your next hire. Margin expansion from $15K to $150K ACV changes the unit economics — you stop optimizing for self-serve conversion and start optimizing for retention.

SkepticGPT-5.4$0.021.5k

No turns yet

PragmatistHaiku 4.5$0.032.3k

No turns yet

Propose. Challenge. Resolve.

Propose

An agent commits to a position. Specific, falsifiable, with the trade-off named up front.

Take the enterprise contracts. The math is the argument: three six-figure ACVs is 5–8 SMB deals each, switching costs compound, and the window is short. Decline now and those buyers find someone else who builds the SSO and audit logs you would have built anyway.

The ARR mix reshapes the conversation with your next investor and your next hire. Margin expansion from $15K to $150K ACV changes the unit economics — you stop optimizing for self-serve conversion and start optimizing for retention.

Challenge

Another agent names the failure mode. No hedging, no on-the-other-hand. The strongest counter on the table.

This is the playbook for sales motion whiplash. The pattern: SMB-built company books two enterprise contracts, hires a VP of Enterprise Sales, ships a quarter of feature work that helps no one in the SMB base, and the SMB pipeline starves while the enterprise pipeline takes 9 months to ramp.

The team that got you to $4M ARR sells PLG-flavored land-and-expand. Enterprise wants champion-driven, security-reviewed, six-month-cycle deals with a real CSM. Different muscle. Different comp plan. Different forecast cadence.

You are about to bifurcate the product roadmap on the strength of three deals. That is a market test of three, not a market signal.

Resolve

A concrete recommendation that survives the back-and-forth. Action, condition, and revisit point.

Recommendation. Take the three contracts. Structure them with explicit enterprise-SLA exemptions in the contract language — no four-hour response times, no quarterly business reviews you cannot staff, no custom integration work outside the scoped SOW. Price the SOW work separately if it materializes.

Build SSO, SCIM, and audit logs on a 12-week ship plan; market them to the SMB mid-market in parallel. Do not hire a VP of Enterprise Sales. Do hire a senior CSM at month two whose only job is the three accounts plus the next two that close inbound.

Revisit the dedicated enterprise motion in two quarters with renewal data, expansion ARR, and a real read on whether the SMB pipeline absorbed the infrastructure tailwind. Decide then. Do not decide now on three contracts.

Ten domains. Same adversarial method.

Each domain ships with templates tuned to how that field actually argues.

Software Development

Should we migrate the monolith to microservices, or fix the slow endpoints first?

Business Strategy

Do we chase enterprise contracts now, or double down on our SMB base?

Research Analysis

Is the methodology in this paper rigorous enough to act on the conclusion?

Product Development

Should we ship the half-feature this sprint or delay for the full version?

Debate & Argumentation

Is unconditional basic income net positive for labor markets at scale?

Product Research

Which standing desk under $800 actually holds up after two years of daily use?

Medical Opinions

Given these symptoms and labs, what differentials should I ask about?

Legal Review

What clauses in this employment contract should I push back on before signing?

Investment Analysis

Is the bull case for this small-cap pharma stronger than the dilution risk?

Writing Critique

Does this opening paragraph earn its length, or am I burying the lede?

Four archetypes, distinct by design.

You pick the lineup. Each archetype has a job — they are not interchangeable.

Strategist

Frames the bet, names the trade-off, and stays committed to a position under pressure.

Skeptic

Names the failure mode the proposer is too close to see. Holds the line on under-delivery risk.

Pragmatist

Reframes binaries as sequencing questions. Synthesizes a concrete, testable next step.

Specialist

Brings domain depth: terminology, precedent, the standard of care that generalists miss.

Request access.

We are letting people in slowly. Tell us a little about you and we'll be in touch.